Is there a generic for Strontium chloride sr-89?

Yes. The FDA Orange Book lists 1 approved generic (ANDA) application for Strontium chloride sr-89, referencing the brand METASTRON. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Strontium chloride sr-89?

METASTRON (NDA 020134, Q BIOMED) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Strontium chloride sr-89 are approved?

Strontium chloride sr-89 is approved in the following dosage form: injectable.

FDA Orange Book · active-ingredient family

Strontium chloride sr-89

Strontium chloride sr-89 is approved as 1 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:METASTRON · NDA 020134

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · injectable

Product	Applicant	Application	TE	Approved
METASTRONRLD	Q BIOMED	NDA 020134	AP	Jun 18, 1993

Generic (ANDA) products (1)

Product	Applicant	Application	TE	Approved
STRONTIUM CHLORIDE SR-89	Q BIOMED	ANDA 075941	AP	Jan 06, 2003

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Strontium chloride sr-89 — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo